Volume 13, Number 8—August 2007
Dispatch
Streptococcus sinensis Endocarditis outside Hong Kong
Ilker Uçkay*
, Peter Rohner*, Ignacio Bolivar†, Béatrice Ninet*, Marina Djordjevic*, Vandack Nobre*, Christian Garzoni*, and Jacques Schrenzel*
, Peter Rohner*, Ignacio Bolivar†, Béatrice Ninet*, Marina Djordjevic*, Vandack Nobre*, Christian Garzoni*, and Jacques Schrenzel*
Table
Susceptibility of Streptococcus sinensis–related strain from University Hospitals of Geneva
| Antimicrobial agent | MIC (mg/L) | Interpretation |
|---|---|---|
| Penicillin | 0.064 | Susceptible |
| Ceftriaxone | 0.19 | Susceptible |
| Imipenem | 0.064 | Susceptible |
| Gentamicin | 3 | Intermediate resistant |
| Levofloxacin | 1 | Susceptible |
| Clindamycin | 0.094 | Susceptible |
| Erythromycin | 0.047 | Susceptible |
| Rifampicin | 0.032 | Susceptible |
| Cotrimoxazole | 1 | Susceptible |
| Tetracycline | 0.125 | Susceptible |
| Tigecycline | 0.064 | Susceptible |
| Linezolid | 0.5 | Susceptible |
| Vancomycin | 1 | Susceptible |
| Teicoplanin | 0.25 | Susceptible |
Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.